Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results
In the fourth quarter of 2024, we expect to announce updated data from the VTP-300 program in ongoing clinical trials in chronic hepatitis B at AASLD – The Liver Meeting® 2024 scheduled from November ...